Recursion Pharmaceuticals Inc (RXRX)
9.42
-0.09
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
9.42
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap: 2.239B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.239B |
| May 16, 2024 | 2.260B |
| May 15, 2024 | 2.379B |
| May 14, 2024 | 2.389B |
| May 13, 2024 | 2.253B |
| May 10, 2024 | 2.044B |
| May 09, 2024 | 2.053B |
| May 08, 2024 | 2.042B |
| May 07, 2024 | 2.089B |
| May 06, 2024 | 2.125B |
| May 03, 2024 | 2.101B |
| May 02, 2024 | 2.089B |
| May 01, 2024 | 1.982B |
| April 30, 2024 | 1.859B |
| April 29, 2024 | 1.948B |
| April 26, 2024 | 1.929B |
| April 25, 2024 | 1.862B |
| April 24, 2024 | 1.886B |
| April 23, 2024 | 1.829B |
| April 22, 2024 | 1.805B |
| April 19, 2024 | 1.746B |
| April 18, 2024 | 1.758B |
| April 17, 2024 | 1.774B |
| April 16, 2024 | 1.798B |
| April 15, 2024 | 1.850B |
| Date | Value |
|---|---|
| April 12, 2024 | 1.998B |
| April 11, 2024 | 2.119B |
| April 10, 2024 | 2.038B |
| April 09, 2024 | 2.159B |
| April 08, 2024 | 2.138B |
| April 05, 2024 | 2.107B |
| April 04, 2024 | 2.073B |
| April 03, 2024 | 2.121B |
| April 02, 2024 | 2.083B |
| April 01, 2024 | 2.225B |
| March 28, 2024 | 2.339B |
| March 27, 2024 | 2.386B |
| March 26, 2024 | 2.422B |
| March 25, 2024 | 2.471B |
| March 22, 2024 | 2.462B |
| March 21, 2024 | 2.499B |
| March 20, 2024 | 2.598B |
| March 19, 2024 | 2.523B |
| March 18, 2024 | 2.680B |
| March 15, 2024 | 2.633B |
| March 14, 2024 | 2.530B |
| March 13, 2024 | 2.576B |
| March 12, 2024 | 2.473B |
| March 11, 2024 | 2.433B |
| March 08, 2024 | 2.626B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
866.92M
Minimum
May 11 2022
6.961B
Maximum
Jul 13 2021
2.336B
Average
1.870B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 731.81B |
| Absci Corp | 521.88M |
| Palatin Technologies Inc | 32.27M |
| Oragenics Inc | 10.44M |
| Actinium Pharmaceuticals Inc | 291.88M |
Market Cap Related Metrics
| PS Ratio | 45.50 |
| PEG Ratio | -0.3344 |
| Price to Book Value | 5.581 |
| Price | 9.42 |
| Earnings Yield | -17.20% |
| PEGY Ratio | -0.3344 |